Popular Articles

Common Diabetic Therapy Reduces Risk Of Pancreatic Cancer
Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual"s risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson Cancer Center, published in the Aug. 1 issue of Gastroenterology.

Association of American Medical Colleges Supports Hospital Agreement On Health Care Reform
AAMC (Association of American Medical Colleges) President and CEO Darrell G. Kirch, M.D., issued the following statement on the agreement reached by the hospital community, the Obama administration, and the Senate Finance Committee in support of health care reform:
News of the day
Montana Reports Increase In HIV Diagnoses
There have been 19 new cases of HIV diagnosed in Montana since the beginning of the year, whereas the state usually has an average of about 20 newly diagnosed cases annually, according to a recent report by the state Department of Public Health and Human Services, the AP/KXNet.com reports (AP/KXNet.com, 6/25). Anna Whiting Sorrell, director of the agency, said that reaching 19 cases before the end of June suggests that people might be increasingly putting themselves at risk. Montana STD/HIV Section Supervisor Laurie Kops, said, "It"s just a little bit alarming to us that we"ve got those numbers, but it"s not that we don"t expect those numbers because we think that there are folks out there who don"t know what their status is." Officials are recommending residents be tested on Saturday as part of National HIV Testing Day (Montana"s News Station.com, 6/25).
Public Health

NIH Funds Work At WPI On Regenerating Heart Tissue And Preventing Urinary Tract Infections

Congressman James McGovern, D-Massachusetts, has announced National Institutes of Health (NIH) awards for two researchers at Worcester Polytechnic Institute"s Life Sciences and Bioengineering Center at Gateway Park. Glenn Gaudette, PhD, assistant professor of biomedical engineering at WPI, will receive $403,000 over two years to advance his work using bone marrow derived stem cells to restore function to damaged hearts. Terri Camesano, PhD, associate professor of chemical engineering at WPI, will receive $218,000 over two years to continue her studies of how cranberry juice prevents urinary tract infections. The grants are the first NIH awards for both Gaudette and Camesano, marking an important milestone for the investigators. "I am pleased to see the NIH continues to recognize the vital research being done at WPI," said Congressman McGovern. "The NIH is the gold-standard for biomedical research in the United States, and these awards further extend Worcester"s position as a leading center for the life sciences." Commenting on the new awards and the growing concentration of NIH funded research at the university, W. Grant McGimpsey, WPI"s associate provost for research and graduate studies ad interim, said "receiving NIH funding, after a rigorous review from their peers, is a major achievement for our young investigators. It validates the scholarship and creativity of their work. More important, though, is the progress these and other exciting research programs at WPI are making to help translate basic science discoveries into potential therapies and technologies that will help people." In previous studies, Camesano has shown that cranberry juice hinders the ability of the bacteria E.coli to adhere to the epithelial cells that line the interior of the urinary tract. Bacterial adhesion is the first step toward infection. In the new study, Camesano"s team will analyze how cranberry juice affects the molecular mechanisms involved in that initial latching-on process, using atomic force microscopy to measure the forces involved. The aim is to establish the optimal cranberry juice dose and exposure time to prevent bacterial adhesion. As part of the new study, Camesano will collaborate with Joseph Grocela, MD, a urologist and clinical researcher at the Massachusetts General Hospital, who will provide samples of epithelial cells taken from women who suffer from chronic urinary tract infections (UTIs). Camesano"s lab will observe how the cells react when they are challenged by E.coli and treated with cranberry juice. The goal is to develop a new therapy for UTIs that does not rely on antibiotics. Gaudette"s lab explores the potential for human mesenchymal stem cells (hMSCs), which come from the bone marrow, to regenerate cardiac tissue, thereby helping a damaged heart beat more effectively. Heart attacks cause significant scaring of cardiac tissue, which in turn prevents the scarred area of the heart from contracting to pump blood. Recent studies by Gaudette and others have shown that when hMSCs are injected into a damaged heart, they help improve cardiac function. Working with WPI colleagues George Pins, PhD, associate professor of biomedical engineering, and Marsha Rolle, PhD, assistant professor of biomedical engineering, Gaudette developed a system for seeding biopolymer microthreads with hMSCs, then stitching those threads directly into a damaged heart. The technique significantly improves the ability to place the hMSCs at precise points in the heart to improve function in the damaged area. The new study aims to develop processes for maximizing the number of hMSCs that can be loaded onto the threads, and then to study the effect of the cells on cardiac function in a rat model. Michael Cohen Worcester Polytechnic Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):